Last reviewed · How we verify
influenza vaccine Fluarix, Adjuvanted Fluarix — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
influenza vaccine Fluarix, Adjuvanted Fluarix (influenza vaccine Fluarix, Adjuvanted Fluarix) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| influenza vaccine Fluarix, Adjuvanted Fluarix TARGET | influenza vaccine Fluarix, Adjuvanted Fluarix | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- influenza vaccine Fluarix, Adjuvanted Fluarix CI watch — RSS
- influenza vaccine Fluarix, Adjuvanted Fluarix CI watch — Atom
- influenza vaccine Fluarix, Adjuvanted Fluarix CI watch — JSON
- influenza vaccine Fluarix, Adjuvanted Fluarix alone — RSS
Cite this brief
Drug Landscape (2026). influenza vaccine Fluarix, Adjuvanted Fluarix — Competitive Intelligence Brief. https://druglandscape.com/ci/influenza-vaccine-fluarix-adjuvanted-fluarix. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab